$1.35
-0.07[-4.93%]
At close: Apr 25
$1.35
0[0.00%]
PreMarket: 8:02AM EDT
Nexalin Technology
(NASDAQ:NXL)Latest News for Nexalin Technology Stock (NASDAQ:NXL)
Nexalin Technology Stock (NASDAQ: NXL)
Categories: All
Friday, April 19, 2024
Tuesday, April 16, 2024
Wednesday, April 10, 2024
Tuesday, April 09, 2024
Monday, April 08, 2024
Thursday, April 04, 2024
Tuesday, April 02, 2024
- Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Apr 2, 2024, 1:23PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Apr 2, 2024, 12:31PM
- Nexalin Technology Granted U.S. Patent #11944806: Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomniaCharles Gross - Apr 2, 2024, 12:01PM
Friday, March 29, 2024
Thursday, March 28, 2024
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Mar 28, 2024, 12:31PM
- Nexalin Technology shares are trading higher after the company announced results of a clinical study evaluating its Gen-2 tACS device for reducing pain in veteran patients with Mild Traumatic Brain Injury.Benzinga Newsdesk - Mar 28, 2024, 9:21AM
- Nexalin Technology Announces Results Of Clinical Study Validating Its Gen-2 tACS Device For Reducing Pain Among Veterans With Mild Traumatic Brain Injury At University Of California, San DiegoBenzinga Newsdesk - Mar 28, 2024, 8:36AM
Thursday, March 21, 2024
Wednesday, March 20, 2024
Thursday, March 14, 2024
Tuesday, March 12, 2024
Monday, March 11, 2024
Friday, March 08, 2024
- Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Mar 8, 2024, 1:47PM
- Nasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In FebruaryAvi Kapoor - Mar 8, 2024, 9:42AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Mar 8, 2024, 8:09AM
Thursday, March 07, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Mar 7, 2024, 4:31PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Mar 7, 2024, 12:31PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Mar 7, 2024, 8:06AM
Wednesday, March 06, 2024
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Mar 6, 2024, 4:31PM
- Nexalin Technology shares are trading higher after the company announced results of a clinical study of its Gen-2 tACS device for the treatment of chronic insomnia.Benzinga Newsdesk - Mar 6, 2024, 1:20PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Mar 6, 2024, 12:31PM
- Nexalin Technology Announces Results From Clinical Study Of Its Gen-2 tACS Device For Treating Adult Patients With Chronic Insomnia; Study Demonstrated Clinically Meaningful And Statistically Significant Improvements In Key Sleep ParametersBenzinga Newsdesk - Mar 6, 2024, 8:32AM
Friday, February 23, 2024
Monday, February 19, 2024
Thursday, February 08, 2024
Tuesday, January 23, 2024
Friday, January 19, 2024
Monday, December 18, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Dec 18, 2023, 4:31PM
- Nexalin Technology Reported The Results Of A Study In Patients With Treatment-Resistant Depression, Concerning Potential Therapeutic Benefits Of Its Second-Generation 15 Milliamp Neurostimulation DeviceBenzinga Newsdesk - Dec 18, 2023, 8:33AM
Tuesday, December 12, 2023
Tuesday, December 05, 2023
Tuesday, November 28, 2023
Wednesday, November 22, 2023
Friday, October 27, 2023
Thursday, October 26, 2023
Monday, October 23, 2023
Wednesday, October 18, 2023
Monday, October 16, 2023
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Oct 16, 2023, 1:31PM
- Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Oct 16, 2023, 1:09PM
- Nexalin Technology Announces Publication Of Groundbreaking Deep-Brain Stimulation Study In Leading Peer-Reviewed Journal; Validates The Ability Of Nexalin's Neurostimulation Device To Penetrate Deep Brain StructuresBenzinga Newsdesk - Oct 16, 2023, 8:46AM